HRP20140922T1 - Postupak dobivanja nebivolola - Google Patents

Postupak dobivanja nebivolola Download PDF

Info

Publication number
HRP20140922T1
HRP20140922T1 HRP20140922AT HRP20140922T HRP20140922T1 HR P20140922 T1 HRP20140922 T1 HR P20140922T1 HR P20140922A T HRP20140922A T HR P20140922AT HR P20140922 T HRP20140922 T HR P20140922T HR P20140922 T1 HRP20140922 T1 HR P20140922T1
Authority
HR
Croatia
Prior art keywords
formula
compound
halogenmethyllithium
derivative
image
Prior art date
Application number
HRP20140922AT
Other languages
English (en)
Inventor
Yvon Derrien
Eric Chenard
Alain Burgos
Original Assignee
Zach System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zach System filed Critical Zach System
Publication of HRP20140922T1 publication Critical patent/HRP20140922T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/66Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Claims (16)

1. Postupak dobivanja spoja formule [image] , gdje je X atom halogena, naznačen time što se sastoji u reakciji spoja formule [image] , gdje je R (C1-C6)-alkilna skupina, s derivatom halogenmetillitija formule Li-CH2-X, u kojoj je X definiran kao gore.
2. Postupak u skladu s patentnim zahtjevom 1, naznačen time što se derivat halogenmetillitija dobiva u reakcijskom sustavu.
3. Postupak u skladu s patentnim zahtjevom 2, naznačen time što se derivat halogenmetillitija dobiva dodavanjem organolitijskog reagensa dihalogenmetanu.
4. Postupak u skladu s patentnim zahtjevom 3, naznačen time što je dihalogenmetan bromklormetan.
5. Postupak u skladu s patentnim zahtjevom 3 ili zahtjevom 4, naznačen time što je organolitijski reagens n-butillitij.
6. Postupak u skladu s bilo kojim od patentnih zahtjeva 3 do 5, naznačen time što se spoj formule (VI), dihalogenmetan i organolitijski reagens upotrebljava u molarnom omjeru od otprilike 1:2:2.
7. Postupak u skladu s bilo kojim od prethodnih zahtjeva, naznačen time što je derivat halogenmetillitija klormetillitij.
8. Postupak u skladu s bilo kojim od prethodnih zahtjeva, naznačen time što se reakciju spoja formule VI s derivatom halogenmetillitija provodi u prisutnosti otapala.
9. Postupak u skladu s patentnim zahtjevom 8, naznačen time što je otapalo tetrahidrofuran (THF).
10. Postupak u skladu s patentnim zahtjevom 1, naznačen time što se dodavanje halogenmetillitija spoju formule (VI) provodi u rasponu temperatura od –100 °C do 0 °C.
11. Postupak u skladu s patentnim zahtjevom 10, naznačen time što se dodavanje halogenmetillitija provodi u rasponu temperatura od –85 °C do –50 °C.
12. Postupak dobivanja spoja formule [image] , naznačen time što se sastoji u prevođenju spoja formule (VI) u spoj formule (I) postupkom u skladu s patentnim zahtjevom 1.
13. Postupak u skladu s patentnim zahtjevom 12, naznačen time što se dodatno sastoji u reduciranju spoja formule I kako bi se dobilo spoj formule (VIII): [image] , u kojoj je X atom halogena, i reakciji navedenog spoja formule (VIII) s bazom kako bi se dobilo epoksidni spoj formule (VII).
14. Postupak dobivanja spoja formule [image] , naznačen time što se sastoji u reakciji spoja formule [image] , u kojoj je R (C1-C6)-alkilna skupina, s derivatom halogenmetillitija formule Li-CH2-X, u kojoj je X atom halogena, kako bi se dobilo reakcijsku smjesu; reduciranju navedene reakcijske smjese na licu mjesta; i cikliziranju u prisutnosti baze.
15. Postupak dobivanja nebivolola, naznačen time što se sastoji u prevođenju spoja formule (VI) u spoj formule (I) postupkom u skladu s patentnim zahtjevom 1.
16. Postupak dobivanja nebivolola, naznačen time što se sastoji u prevođenju u jednoj posudi spoja formule (VI) u spoj formule (VII) postupkom u skladu s patentnim zahtjevom 14.
HRP20140922AT 2008-09-24 2014-09-26 Postupak dobivanja nebivolola HRP20140922T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0856415 2008-09-24
PCT/FR2009/051775 WO2010034927A1 (fr) 2008-09-24 2009-09-22 Procede de preparation de nebivolol

Publications (1)

Publication Number Publication Date
HRP20140922T1 true HRP20140922T1 (hr) 2014-11-07

Family

ID=40527387

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20140922AT HRP20140922T1 (hr) 2008-09-24 2014-09-26 Postupak dobivanja nebivolola

Country Status (12)

Country Link
US (1) US8981127B2 (hr)
EP (1) EP2328883B1 (hr)
JP (1) JP5744738B2 (hr)
CN (1) CN102164906A (hr)
AU (1) AU2009295730B2 (hr)
BR (1) BRPI0919257B8 (hr)
CA (1) CA2736600C (hr)
ES (1) ES2523343T3 (hr)
HR (1) HRP20140922T1 (hr)
IL (1) IL211410A (hr)
PL (1) PL2328883T3 (hr)
WO (1) WO2010034927A1 (hr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102180855B (zh) * 2011-03-01 2015-11-25 浙江华海药业股份有限公司 一种奈必洛尔中间体的提纯方法
ITRM20110418A1 (it) 2011-08-02 2013-02-03 Menarini Int Operations Lu Sa Processo per la preparazione di epossidi quali intermedi per la sintesi del nebivololo.
PT2907809T (pt) 2014-02-14 2019-01-16 Corden Pharma Int Gmbh Processo sem base para a preparação de intermediários de cetona utilizáveis para fabrico de nebivolol
CN104610215A (zh) * 2015-01-19 2015-05-13 浙江海翔药业股份有限公司 一种奈必洛尔中间体的制备方法及奈必洛尔的制备方法
ITUB20160227A1 (it) * 2016-01-21 2017-07-21 Menarini Int Operations Luxembourg Sa Processo per la sintesi di intermedi di Nebivololo
CN108997297B (zh) * 2018-07-17 2020-12-01 浙江海翔药业股份有限公司 一种奈必洛尔中间体的制备方法、用于制备该奈必洛尔中间体的中间体及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591885A (en) 1994-09-23 1997-01-07 Hoffman-La Roche Inc. Process for the preparation of halogenated α-aminoketone compounds
US5523463A (en) * 1994-09-23 1996-06-04 Hoffmann-La Roche Inc. Method of producing halogenated and alpha-aminoalchohols
US6127556A (en) * 1996-12-31 2000-10-03 G. D. Searle & Co. Epoxide formation by continuous in-situ synthesis process
EP1534683A4 (en) * 2002-06-27 2005-08-24 Nitromed Inc CYCLOOXYGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHOD OF USE
EP1937649A1 (en) * 2005-10-14 2008-07-02 Neurosearch A/S Imidazole derivatives for the treatment of anxiety and related diseases
US7560575B2 (en) * 2005-12-28 2009-07-14 Acino Pharma Ag Process for preparation of racemic Nebivolol
ITMI20061889A1 (it) * 2006-10-03 2008-04-04 Zambon Spa Processo di preparazione di nebivololo
EP2061759B1 (en) * 2006-10-04 2013-03-27 Bristol-Myers Squibb Company Cyclic modulators of chemokine receptor activity
NZ582249A (en) * 2007-06-28 2012-06-29 Intervet Int Bv Substituted piperazines as cb1 antagonists

Also Published As

Publication number Publication date
AU2009295730A1 (en) 2010-04-01
WO2010034927A1 (fr) 2010-04-01
EP2328883B1 (fr) 2014-08-06
AU2009295730B2 (en) 2013-12-19
PL2328883T3 (pl) 2015-01-30
CN102164906A (zh) 2011-08-24
BRPI0919257A2 (pt) 2015-08-18
EP2328883A1 (fr) 2011-06-08
IL211410A (en) 2015-10-29
BRPI0919257B1 (pt) 2021-05-04
CA2736600C (fr) 2017-03-21
IL211410A0 (en) 2011-05-31
US8981127B2 (en) 2015-03-17
CA2736600A1 (fr) 2010-04-01
JP5744738B2 (ja) 2015-07-08
BRPI0919257B8 (pt) 2021-05-25
JP2012503636A (ja) 2012-02-09
ES2523343T3 (es) 2014-11-25
US20110237808A1 (en) 2011-09-29

Similar Documents

Publication Publication Date Title
HRP20140922T1 (hr) Postupak dobivanja nebivolola
CA2510093A1 (en) Novel process for the preparation of.alpha.-chlorovinyl, .alpha.,.alpha.-dichloro, and acetylenes from ketones
MY198064A (en) Method for preparing 3-trifluoromethyl chalcones
PE20060649A1 (es) Forma polimorfa ii de rapamicina y proceso de preparacion
NO20092960L (no) Krystallinsk minocycline base og framgangsmater for framstilling av denne
Imai et al. First catalytic and enantioselective synthesis of silyl and stannyl substituted cyclopropylmethanols
Xie et al. Efficient and mild synthesis of functionalized 2, 3-dihydrofuran derivatives via domino reaction in water
CN104520275B (zh) 用于制备整合酶抑制剂的方法和中间产物
HRP20110418T1 (hr) Kristalizacija čvrstih oblika adicijskih soli klopidogrela
EP2178871A2 (en) Cyclic ethers
CN105175299A (zh) 使用二氧化硒制备2,2’-二芳基硒醚或者4,4’-二芳基硒醚的方法
JP2011519860A5 (hr)
HRP20160740T1 (hr) Postupak pripreme nebivolola
Liang et al. Catalytic asymmetric brominative dearomatization reaction of benzofurans
JP2016535033A (ja) 活性化されていない第二級ボロン酸のクロスカップリング
CN112940036B (zh) 一种苯并噻唑磷酸酯化合物的制备方法
Suzuki et al. Formal synthesis of (+)-isolaurepinnacin
WO2010011546A3 (en) Pyrrolo [3, 2-b]pyridines and pyrazolo [4, 3 -b] pyridines having 5-ht6 receptor affinity
Pandey et al. Imino-ene reaction of N-tosyl arylaldimines with α-methylstyrene: application in the synthesis of important amines
EP2816044A1 (en) Intermediate for acenedichalcogenophene derivative and method for synthesizing same
Mandai et al. Bacteriogenic iron oxide as an effective catalyst for Baeyer-Villiger oxidation with molecular oxygen and benzaldehyde
CN106928165A (zh) 一种四氢糠基醚类化合物的制备方法
WO2007077485A3 (en) Method for producing metallocenes
HRP20141087T1 (hr) Sintetički međuproizvod spoja oksazola i postupak za njegovu proizvodnju
WO2009079578A8 (en) Low voc waterbased coatings with efflorescence resistance